Abstract
PO55: High Dose Rate Brachytherapy Boost versus Monotherapy in Unfavourable-Intermediate and High Risk Localized Prostate Cancer: Retrospective Australian Single-Institutional Experience with Long-Term Follow-Up
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have